Active Pharmaceutical Ingredient (API)

Benralizumab

Anti-Eosinophil Monoclonal Antibody

Binds to the alpha subunit of the IL-5 receptor. It induces direct, rapid depletion of eosinophils via antibody-dependent cell-mediated cytotoxicity (ADCC).
Technical Profile
Reference Code
RES964
CAS Number
1044511-43-8
Molecular Weight
147,000.00 g/mol
Chemical Class
N/A
Molecular Formula
C6470H10010N1722O2020S42
Therapeutic Class
N/A

Verified Brands

Medicines containing Benralizumab as an active ingredient.

Brand Name Manufacturer Formulation MRP
No verified brands found for this salt.